Bruno Larrivée
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 7
- Genetics top 2%
- Vascular Anomalies and Treatments 6
- Molecular Biology top 5%
- Angiogenesis and VEGF in Cancer 25
- Oncology top 5%
- Lymphatic System and Diseases 4
-
- Axon Guidance and Neuronal Signaling 7
-
- Vascular Malformations and Hemangiomas 6
-
- Zebrafish Biomedical Research Applications 5
-
- Innovative Microfluidic and Catalytic Techniques Innovation 4
- Co-authors
- Claire ViallardAnne EichmannAly KarsanThomas MathivetCatarina FreitasClaudia PrahstAntónio DuarteSteven Suchting
- Partner nations
- CanadaFranceUnited States
In The Last Decade
Bruno Larrivée
50 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 792
- Genetics 459
- Molecular Biology 2.5k
- Oncology 861
- Cellular and Molecular Neuroscience 527
Countries citing papers authored by Bruno Larrivée
This map shows the geographic impact of Bruno Larrivée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Larrivée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Larrivée more than expected).
Fields of papers citing papers by Bruno Larrivée
This network shows the impact of papers produced by Bruno Larrivée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Larrivée. The network helps show where Bruno Larrivée may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bruno Larrivée, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 19 | |
| 2 | 2022 | 12 | |
| 3 | 2020 | 27 | |
| 4 | 2019 | 19 | |
| 5 | 2018 | 54 | |
| 6 | Tumor angiogenesis and vascular normalization: alternative therapeutic targetsbreakdown → | 2017 | 1100 |
| 7 | 2016 | 123 | |
| 8 | 2013 | 27 | |
| 9 | 2012 | 56 | |
| 10 | 2012 | 289 | |
| 11 | 2012 | 53 | |
| 12 | 2008 | 52 | |
| 13 | 2008 | 42 | |
| 14 | 2007 | 16 | |
| 15 | 2006 | 6 | |
| 16 | 2005 | 57 | |
| 17 | 2005 | 29 | |
| 18 | 2005 | 7 | |
| 19 | 2003 | 34 | |
| 20 | 1998 | 6 |
About Bruno Larrivée
Bruno Larrivée is a scholar working on Immunology and Allergy, Cancer Research and Genetics, having authored 51 papers that have together received 4.2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (25 papers), Axon Guidance and Neuronal Signaling (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Vascular Anomalies and Treatments (6 papers), Vascular Malformations and Hemangiomas (6 papers), Zebrafish Biomedical Research Applications (5 papers), Innovative Microfluidic and Catalytic Techniques Innovation (4 papers) and Lymphatic System and Diseases (4 papers). The work is most often cited by research in Cancer Research (792 citations), Genetics (459 citations) and Molecular Biology (2.5k citations). Bruno Larrivée has collaborated with scholars based in Canada, France and United States. Frequent co-authors include Claire Viallard, Anne Eichmann, Aly Karsan, Thomas Mathivet, Catarina Freitas, Claudia Prahst, António Duarte, Steven Suchting, Christiane Bréant and Michael Simons. Their work appears in journals such as Scientific Reports, Blood, Angiogenesis, Circulation Research and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.